Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Stevenson

Showing results (241-250 of 288) with videos related to

Pageof 29
Sort By:
Nature Chemical Biology|July 28, 2014
Endosomal GPCR signaling turned off by negative feedback actions of PKA and v-ATPaseAlexandre Gidon, Mohammad M Al-Bataineh, Frederic G Jean-Alphonse, et al.
The International Journal of Oral & Maxillofacial Implants|May 15, 1998
A 5-year multicenter study on implant-supported single crown restorationsH Scheller, J P Urgell, C Kultje, et al.
Cancer|May 1, 2012
Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nonsmall cell lung cancerJames P Stevenson, Corey J Langer, Robert A Somer, et al.
Cancer|February 3, 2011
Adjuvant radiotherapy for completely resected stage 2 thymomaAbigail T Berman, Leslie Litzky, Virginia Livolsi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flowJames P Stevenson, Mark Rosen, Weijing Sun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecanR S Midgley, D J Kerr, K T Flaherty, et al.
JCO Precision Oncology|February 9, 2022
Precision Oncology in Solid Tumors: A Longitudinal Tertiary Care Center ExperienceMeena Sadaps, Pauline Funchain, Haider Mahdi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small cell lung cancer: a report of toxicities and clinical responseRamesh Rengan, Rosemarie Mick, Daniel Pryma, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non-small-cell lung cancer: KEYNOTE-021 cohorts D and HMatthew A Gubens, Lecia V Sequist, James P Stevenson, et al.
Oncoimmunology|November 2, 2013
Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patientsJames P Stevenson, Hedy L Kindler, Emmanouil Papasavvas, et al.
Pageof 29

Showing results (241-250 of 288) with videos related to

Sort By:
Pageof 29
Nature Chemical Biology|July 28, 2014
Endosomal GPCR signaling turned off by negative feedback actions of PKA and v-ATPaseAlexandre Gidon, Mohammad M Al-Bataineh, Frederic G Jean-Alphonse, et al.
The International Journal of Oral & Maxillofacial Implants|May 15, 1998
A 5-year multicenter study on implant-supported single crown restorationsH Scheller, J P Urgell, C Kultje, et al.
Cancer|May 1, 2012
Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nonsmall cell lung cancerJames P Stevenson, Corey J Langer, Robert A Somer, et al.
Cancer|February 3, 2011
Adjuvant radiotherapy for completely resected stage 2 thymomaAbigail T Berman, Leslie Litzky, Virginia Livolsi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flowJames P Stevenson, Mark Rosen, Weijing Sun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecanR S Midgley, D J Kerr, K T Flaherty, et al.
JCO Precision Oncology|February 9, 2022
Precision Oncology in Solid Tumors: A Longitudinal Tertiary Care Center ExperienceMeena Sadaps, Pauline Funchain, Haider Mahdi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small cell lung cancer: a report of toxicities and clinical responseRamesh Rengan, Rosemarie Mick, Daniel Pryma, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non-small-cell lung cancer: KEYNOTE-021 cohorts D and HMatthew A Gubens, Lecia V Sequist, James P Stevenson, et al.
Oncoimmunology|November 2, 2013
Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patientsJames P Stevenson, Hedy L Kindler, Emmanouil Papasavvas, et al.
Pageof 29